These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33441450)

  • 1. Bayesian estimation of SARS-CoV-2 prevalence in Indiana by random testing.
    Yiannoutsos CT; Halverson PK; Menachemi N
    Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33441450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample - Indiana, April 25-29, 2020.
    Menachemi N; Yiannoutsos CT; Dixon BE; Duszynski TJ; Fadel WF; Wools-Kaloustian KK; Unruh Needleman N; Box K; Caine V; Norwood C; Weaver L; Halverson PK
    MMWR Morb Mortal Wkly Rep; 2020 Jul; 69(29):960-964. PubMed ID: 32701938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in COVID-19 Diagnosis by Zip Code and Race and Ethnicity in Indiana.
    Hanson AE; Hains DS; Schwaderer AL; Starr MC
    Front Public Health; 2020; 8():593861. PubMed ID: 33363087
    [No Abstract]   [Full Text] [Related]  

  • 4. Performance of Three Tests for SARS-CoV-2 on a University Campus Estimated Jointly with Bayesian Latent Class Modeling.
    Perkins TA; Stephens M; Alvarez Barrios W; Cavany S; Rulli L; Pfrender ME
    Microbiol Spectr; 2022 Feb; 10(1):e0122021. PubMed ID: 35044220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating seroprevalence of SARS-CoV-2 in Ohio: A Bayesian multilevel poststratification approach with multiple diagnostic tests.
    Kline D; Li Z; Chu Y; Wakefield J; Miller WC; Norris Turner A; Clark SJ
    Proc Natl Acad Sci U S A; 2021 Jun; 118(26):. PubMed ID: 34172581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple Questionnaires to Improve Pooling Strategies for SARS-CoV-2 Laboratory Testing.
    Schneitler S; Jung P; Bub F; Alhussein F; Benthien S; Berger FK; Berkó-Göttel B; Eisenbeis J; Hahn D; Halfmann A; Last K; Linxweiler M; Lohse S; Papan C; Pfuhl T; Rissland J; Roth S; Schlotthauer U; Utzinger J; Smola S; Gärtner BC; Becker SL
    Ann Glob Health; 2020 Nov; 86(1):148. PubMed ID: 33262937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States.
    Bailey LC; Razzaghi H; Burrows EK; Bunnell HT; Camacho PEF; Christakis DA; Eckrich D; Kitzmiller M; Lin SM; Magnusen BC; Newland J; Pajor NM; Ranade D; Rao S; Sofela O; Zahner J; Bruno C; Forrest CB
    JAMA Pediatr; 2021 Feb; 175(2):176-184. PubMed ID: 33226415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community Coronavirus Disease 2019 Activity Level and Nursing Home Staff Testing for Active Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Indiana.
    Blackburn J; Weaver L; Cohen L; Menachemi N; Rusyniak DE; Unroe KT
    J Am Med Dir Assoc; 2021 Jan; 22(1):204-208.e1. PubMed ID: 33248030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 testing in North Carolina: Racial, ethnic, and geographic disparities.
    Brandt K; Goel V; Keeler C; Bell GJ; Aiello AE; Corbie-Smith G; Wilson E; Fleischauer A; Emch M; Boyce RM
    Health Place; 2021 May; 69():102576. PubMed ID: 33915376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of Novel Coronavirus SARS-CoV-2 at a Community Hospital Emergency Department and Outpatient Laboratory in Northern Orange County, California.
    Yamaki J; Peled H; Mathews S; Park D; Firoozi M; Smith K; Nguyen L
    J Racial Ethn Health Disparities; 2021 Dec; 8(6):1551-1555. PubMed ID: 33230735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, Risk Factors, and Outcomes of Hospitalized Patients With Coronavirus Disease 2019 Presenting as Acute Pancreatitis.
    Inamdar S; Benias PC; Liu Y; Sejpal DV; Satapathy SK; Trindade AJ;
    Gastroenterology; 2020 Dec; 159(6):2226-2228.e2. PubMed ID: 32860787
    [No Abstract]   [Full Text] [Related]  

  • 13. Health Center Testing for SARS-CoV-2 During the COVID-19 Pandemic - United States, June 5-October 2, 2020.
    Romero L; Pao LZ; Clark H; Riley C; Merali S; Park M; Eggers C; Campbell S; Bui C; Bolton J; Le X; Fanfair RN; Rose M; Hinckley A; Siza C
    MMWR Morb Mortal Wkly Rep; 2020 Dec; 69(50):1895-1901. PubMed ID: 33332299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demographic and clinical correlates of acute and convalescent SARS-CoV-2 infection among patients of a U.S. emergency department.
    Laeyendecker O; Hsieh YH; Rothman RE; Dashler G; Kickler T; Fernandez RE; Clarke W; Patel EU; Tobian AAR; Kelen GD; Quinn TC;
    Am J Emerg Med; 2021 Oct; 48():261-268. PubMed ID: 34015609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating SARS-CoV-2 infections from deaths, confirmed cases, tests, and random surveys.
    Irons NJ; Raftery AE
    Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34312227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal screening for SARS-CoV-2 infection: a rapid review.
    Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of High-Sensitivity Severe Acute Respiratory Syndrome Coronavirus 2 Testing for Stool-Toward the New Normal for Fecal Microbiota Transplantation.
    Babiker A; Ingersoll JM; Adelman MW; Webster AS; Broder KJ; Stittleburg V; Waggoner JJ; Kraft CS; Woodworth MH
    Clin Transl Gastroenterol; 2021 Jun; 12(6):e00363. PubMed ID: 34106090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro diagnostics of coronavirus disease 2019: Technologies and application.
    Lai CC; Wang CY; Ko WC; Hsueh PR
    J Microbiol Immunol Infect; 2021 Apr; 54(2):164-174. PubMed ID: 32513617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses.
    Mutnal MB; Arroliga AC; Walker K; Mohammad A; Brigmon MM; Beaver RM; Midturi JK; Rao A
    J Med Virol; 2020 Oct; 92(10):2130-2138. PubMed ID: 32410236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.